Biology and Medicine

Nanorx Inc, PO Box 131, Chappaqua, NY, USA

Biography

Dr. Raghavan PR is an  Experienced Chief Executive Officer with a demonstrated history of working in the pharmaceuticals industry. Skilled in Nano technology, Patent Law, Biotechnology, Drug Development, Drug Discovery, and Licensing and International marketing. Strong entrepreneurship professional graduated with a Ph.D (Organic Chemistry) from Oregon State University, Corvallis, Oregon, USA

Publications

• Research Article   
  Metadichol® A Novel Inverse Agonist of Thyroid Receptor and its Applications in Thyroid Diseases
  Author(s): Raghavan PR*
  
  An estimated 200 million individuals worldwide have a thyroid disorder. Thyroid diseases affect seven times more women than men. People not diagnosed make up the majority of thyroid patients. There is a need to find novel and safe ways to change the underlying disease processes, rather than merely stop excess thyroid hormone production as in hypothyroidism. Metadichol® is a nano emulsion of an extract of long-chain alcohols from food that is an inverse agonist of VDR (Vitamin D receptor), AHR (Aryl Hydrocarbon Receptor), and RORC (RAR Related Orphan Receptor C). The work presented here shows that Metadichol® is an inverse agonist of THRA (Thyroid Receptor Alpha) and THRB (Thyroid Receptor Beta). Case studies are presented that show how it can safely treat a multitue of thyroid related diseases. Network and pathway enrichment studies are presented that show how Metadicho.. View more»
  

  DOI: 10.35248/0974-8369.19.11.458

  Abstract HTML PDF